Human Subjects Mechanistic and Minimal Risk Studies (R21 Clinical Trial Optional)

The summary for the Human Subjects Mechanistic and Minimal Risk Studies (R21 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Human Subjects Mechanistic and Minimal Risk Studies (R21 Clinical Trial Optional): The purpose of this FOA is to encourage applications that seek to conduct studies of the visual system. Eligible applications may be either: Those that involve human subjects, but are not NIH-defined clinical trials (see NOT-OD-15-015); or Those that are NIH-defined clinical trials and are designed to address either: 1) mechanisms underlying human vision in health and disease; or 2) interventions that entail procedures with minimal risk to subjects. More information about eligibility can be found in Part 2 Section III.3. A mechanistic trial is defined as "A study designed to understand a biological or behavioral process, the pathophysiology of a disease, or the mechanism of action of an intervention. "Minimal risk" means that the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests. NIH-defined clinical trial applications that are neither mechanistic nor minimal risk are not eligible for this FOA. Large-scale clinical trials, human gene-transfer and stem cell therapy trials, and other complex or high resource- or safety-risk clinical trials are not appropriate for this FOA. Applicants are strongly advised to consult with NEI program staff prior to submitting an application with human subjects to determine the appropriate funding opportunity.
Federal Grant Title: Human Subjects Mechanistic and Minimal Risk Studies (R21 Clinical Trial Optional)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-18-500
Type of Funding: Grant
CFDA Numbers: 93.867
CFDA Descriptions: Information not provided
Current Application Deadline: January 7th, 2021
Original Application Deadline: January 7th, 2021
Posted Date: December 15th, 2017
Creation Date: December 15th, 2017
Archive Date: February 12th, 2021
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: December 15th, 2017
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-18-500.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required)
NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinica...
NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Requ...
NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integ...
Human Subjects Mechanistic and Minimal Risk Studies (R01 Clinical Trial Optional)
Nei Career Transition Award (K22)
NEI Translational Research Program On Therapy For Visual Disorders
NEI Clinical Study Planning Grant Program (R34)
More Grants from the National Institutes of Health
Analytical Validation of Candidate Biomarkers for Neurological Disease (U01 Clinical Trial...
Limited Competition: Revision Applications for International Centers of Excellence for Mal...
Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Tr...
Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Tria...
Limited Competition: Data Analysis and Coordination Center for the MACS/WIHS Combined Coho...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com